ArticleDiscover oncology2025

Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy.

Bo-Ya Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.